Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page’s site revision number was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov record for the COVID-19 coagulopathy study is displayed with its study design, participant criteria, interventions, outcome measures, investigators, publications, and supporting documents.SummaryDifference50%

- Check21 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.